|
GDI2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.304700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.964470E-02 |
| Normal-vs-Stage2 |
3.340900E-03 |
| Normal-vs-Stage3 |
2.488000E-02 |
| Normal-vs-Stage4 |
8.796000E-02 |
| Stage1-vs-Stage2 |
1.851150E-01 |
| Stage1-vs-Stage3 |
7.240000E-01 |
| Stage1-vs-Stage4 |
9.681000E-01 |
| Stage2-vs-Stage3 |
3.441000E-01 |
| Stage2-vs-Stage4 |
2.941000E-01 |
| Stage3-vs-Stage4 |
8.394200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.136000E-03 |
| Normal-vs-AfricanAmerican |
9.075800E-01 |
| Normal-vs-Asian |
2.492500E-02 |
| Caucasian-vs-AfricanAmerican |
8.610100E-02 |
| Caucasian-vs-Asian |
8.111000E-01 |
| AfricanAmerican-vs-Asian |
5.970400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.858360E-02 |
| Normal-vs-Female |
1.005610E-02 |
| Male-vs-Female |
8.186000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.621700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.484800E-03 |
| Normal-vs-Age(61-80Yrs) |
6.809800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.175200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.941170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.929000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.883000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.193000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.891200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.300400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.957800E-01 |
| Classical-VS-Follicular |
5.732500E-02 |
| Classical-VS-Other |
8.505800E-02 |
| Classical-VS-Normal |
7.640300E-02 |
| Tall-VS-Follicular |
1.125970E-01 |
| Tall-VS-Other |
1.001240E-01 |
| Tall-VS-Normal |
5.479200E-01 |
| Follicular-VS-Other |
4.559000E-01 |
| Follicular-VS-Normal |
3.116800E-03 |
| Other-VS-Normal |
1.177700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.215700E-03 |
| Normal-vs-N1 |
7.410300E-04 |
| N0-vs-N1 |
1.371180E-01 |
|
|
